SAN DIEGO, Feb. 10, 2023 (GLOBE NEWSWIRE) — The Shareholders Foundation, Inc. announces that a lawsuit has been filed against certain investors of Caribou Biosciences, Inc. CRBU shares.

Investors who have suffered losses greater than $200,000 on Caribou Biosciences, Inc. shares. CRBU have certain options and short and strict deadlines apply. Deadline: April 11, 2023. NASDAQ: CRBU investors should contact the Shareholders Foundation at mail@aktionärsstiftung.com or call +1(858) 779-1554.

On February 10, 2023, a lawsuit was filed against Caribou Biosciences, Inc. Plaintiff alleges that the offering materials issued in connection with the Company’s IPO on July 23, 2021 were prepared negligently and as a result contained false statements of fact or omissions of other facts necessary to ensure that the statements made are not misleading , and which have not been created in accordance with the rules and regulations governing their creation. In addition, Plaintiff alleges that between July 23, 2021 and December 9, 2022, Defendants made materially false and misleading statements about the Company’s business, operations and prospects.

More specifically, Plaintiff alleges that the IPO offering documents and Defendants made false and/or misleading statements and/or failed to disclose that the treatment effects of CB-010 were not as permanent as Defendants led investors to believe clinical and commercial prospects of CB-010 were overstated and that as a result, between July 23, 2021 and December 9, 2022, Defendants’ offering documents and public statements were materially false and/or misleading and did not contain the required information stated therein.

Those who have purchased NASDAQ: CRBU stock should contact the Shareholders Foundation, Inc.

CONTACT:
Shareholder Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@aktionärsstiftung.com
3111 Camino Del Rio North
Episode 423
San…